Vertex Pharmaceuticals develops and sells prescription medicines for cystic fibrosis, blood disorders, acute pain and serious kidney diseases. It last closed at $534.20 on Nov 17, down 0.67% on the day. VRTX reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 11 analysts is $626.18 (+17.2% from the last close), with a high of $725.00 and a low of $563.00. Analyst consensus is Strong Buy, based on the latest ratings from 11 firms (10 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in VRTX, 50% of them bullish and 50% bearish. In the past 30 days there were 13 dark pool prints totaling $27.7M, the largest $16.3M.
Each firm's latest rating on VRTX in the past 90 days
Average 12-month target
$626.18
▲ 17.2% upside
Based on 11 analysts who set a price target on VRTX in the past 90 days. The average target is $626.18, with a high of $725.00 and a low of $563.00, compared with the last close of $534.20.
Low $563.00Avg $626.18High $725.00
Blue marker: last close $534.20
Highest target$725.00
Average target$626.18
Lowest target$563.00
Latest rating changes
BarclaysTarget raised
Nov 4Buy$617 → $626
JP MorganTarget raised
Nov 3Buy$560 → $570
Goldman SachsMaintained
Nov 3Buy$725
Morgan StanleyTarget lowered
Nov 3Buy$665 → $660
ScotiabankMaintained
Nov 3Buy$660
Date
Firm
Action
Rating
Price target
Nov 4
Barclays
Target raised
Buy
$617 → $626
Nov 3
JP Morgan
Target raised
Buy
$560 → $570
Nov 3
Goldman Sachs
Maintained
Buy
$725
Nov 3
Morgan Stanley
Target lowered
Buy
$665 → $660
Nov 3
Scotiabank
Maintained
Buy
$660
Loading…
Technical Analysis
VRTX · as of the Nov 17 close · updated after every close
Uptrend
The stock sits between its 20 and 50 day averages. It is 9% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 50). The nearest support is the Pivot at $533.92, and the nearest resistance the swing high (Oct 22) at $537.81.
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 2.8%/day
Key levels
$568.6752 week high+6.5%
$538.84Pivot R1+0.9%
$538.6120 day average+0.8%
$537.81Swing high (Oct 22)+0.7%
$534.20Last close
$533.92Pivot−0.1%
$532.23Swing low (Aug 31)−0.4%
$529.28Pivot S1−0.9%
$522.3150 day average−2.2%
$515.91100 day average−3.4%
$483.99200 day average−9.4%
$412.2752 week low−22.8%
Indicators
RSI (14)
50.38
Middle of its range
Neutral
MACD
5.78
Below its signal line
Bearish
Stochastic
36.7
Middle of its range
Neutral
ADX (14)
12.2
No clear trend
Williams %R
-83.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-31.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.7%
Change over 10 sessions
Bullish
ATR (14)
$15.06
Typical daily range, 2.8% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityNormal, 5.8%/day
Key levels
$568.6752 week high+6.5%
$538.84Pivot R1+0.9%
$538.6120 day average+0.8%
$537.81Swing high (Oct 22)+0.7%
$534.20Last close
$533.92Pivot−0.1%
$532.23Swing low (Aug 31)−0.4%
$529.28Pivot S1−0.9%
$522.3150 day average−2.2%
$515.91100 day average−3.4%
$483.99200 day average−9.4%
$412.2752 week low−22.8%
Indicators
RSI (14)
57.04
Middle of its range
Neutral
MACD
18.04
Above its signal line
Bullish
Stochastic
67.6
Middle of its range
Neutral
ADX (14)
21.6
Weak trend
Williams %R
-40.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
71.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.6%
Change over 10 sessions
Bullish
ATR (14)
$30.91
Typical daily range, 5.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for VRTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VRTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow is mixed2 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow VRTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How VRTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Nov 3, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VRTX is in one of them and how their past VRTX trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Vertex Pharmaceuticals Inc / MA
Vertex Pharmaceuticals is a biotechnology company based in Boston, Massachusetts, that develops and sells prescription medicines for serious diseases. Its approved products treat cystic fibrosis, sickle cell disease and beta thalassemia, and acute pain. The company also has clinical programs for kidney diseases, diabetic nerve pain and type 1 diabetes. Its customers include patients, healthcare providers, and insurers and payors that cover its treatments.